---
figid: PMC4377229__nihms671956f1
figtitle: 'Never Say Die: Survival Signaling in Large Granular Lymphocyte Leukemia'
organisms:
- NA
pmcid: PMC4377229
filename: nihms671956f1.jpg
figlink: /pmc/articles/PMC4377229/figure/F1/
number: F1
caption: Cytotoxic cells kill the target cells by one of the two mechanisms. Activated
  cytotoxic cells upregulate FasL on their surfaces, while target cells express Fas.
  This facilitates Fas-FasL mediated apoptosis in the target cells (upper panel).
  Another mechanism is through exocytosis of cytolytic granules from CTL into the
  target cells. Similar mechanism operates to maintain T-cell homeostasis. CTL use
  Fas-FasL mediated apoptosis to induce apoptosis either in self or another antigen-specific
  T-cells (middle panel). Leukemic LGL, despite expressing abundant Fas and FasL,
  are resistant to Fas-mediated apoptosis. It is believed that survival signaling
  overcomes Fas-mediated apoptotic signals in leukemic LGL leading to their accumulation
  (lower panel). CTL - cytotoxic T-lymphocyte; Mt. pathway – mitochondrial pathway.
papertitle: 'Never Say Die: Survival Signaling in Large Granular Lymphocyte Leukemia.'
reftext: Mithun Vinod Shah, et al. Clin Lymphoma Myeloma. ;9(0 3):S244-S253.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8978167
figid_alias: PMC4377229__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC4377229__F1
ndex: 35e8ac07-de97-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4377229__nihms671956f1.html
  '@type': Dataset
  description: Cytotoxic cells kill the target cells by one of the two mechanisms.
    Activated cytotoxic cells upregulate FasL on their surfaces, while target cells
    express Fas. This facilitates Fas-FasL mediated apoptosis in the target cells
    (upper panel). Another mechanism is through exocytosis of cytolytic granules from
    CTL into the target cells. Similar mechanism operates to maintain T-cell homeostasis.
    CTL use Fas-FasL mediated apoptosis to induce apoptosis either in self or another
    antigen-specific T-cells (middle panel). Leukemic LGL, despite expressing abundant
    Fas and FasL, are resistant to Fas-mediated apoptosis. It is believed that survival
    signaling overcomes Fas-mediated apoptotic signals in leukemic LGL leading to
    their accumulation (lower panel). CTL - cytotoxic T-lymphocyte; Mt. pathway –
    mitochondrial pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ctl
  - cutlet
  - disco
  - Fas1
  - FASN1
  - Fas2
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - l(2)gl
  - lgs
  - Stat92E
  - hop
  - bsk
  - Dif
  - dl
  - Rel
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Dsor1
  - Mtk
  - ras
  - Ras64B
  - Ras85D
  - Erk7
  - rl
  - grb
  - flip
  - S1P
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - FASLG
  - FAS
  - FASN
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MCL1
  - LRP8
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - EPHB2
  - MAPK1
  - MAPK3
  - SERPINB9
  - CFLAR
  - FIRRM
  - RBM14
  - KANK2
  - CACYBP
  - TP53INP1
  - TSACC
  - RBM14-RBM4
  - MBTPS1
  - Ceramide
  - Autoimmune lymphoproliferative syndrome
  - Cancer
---
